Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis. - Wikidata - awgldk - TriplyDB

Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.

Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.

http://www.wikidata.org/entity/Q33980394

about

pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis Base-calling algorithm with vocabulary (BCV) method for analyzing population sequencing chromatograms Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing.Comparison and development of pyrazinamide susceptibility testing methods for tuberculosis in Thailand.Outbreak of pyrazinamide-monoresistant tuberculosis identified using genotype cluster and social media analysis.Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis.Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania.The future of molecular diagnostics for drug-resistant tuberculosis.EthA/R-Independent Killing of Mycobacterium tuberculosis by Ethionamide.Potential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India.Temperature-mediated heteroduplex analysis performed by using denaturing high-performance liquid chromatography to identify sequence polymorphisms in Mycobacterium tuberculosis complex organisms ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, China pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal.Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility.Validation of pncA gene sequencing in combination with the mycobacterial growth indicator tube method to test susceptibility of Mycobacterium tuberculosis to pyrazinamide.A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings.Epidemiologic Correlates of Pyrazinamide-Resistant Mycobacterium tuberculosis in New York City.Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains.Improved Detection by Next-Generation Sequencing of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates.Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance Temperature-mediated heteroduplex analysis for detection of pncA mutations associated with pyrazinamide resistance and differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by denaturing high- performance liquid chromatography Evaluation of methods for testing the susceptibility of clinical Mycobacterium tuberculosis isolates to pyrazinamide.Current issues on molecular and immunological diagnosis of tuberculosis.Correlation between pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan.Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses.Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh.A brief primer on genomic epidemiology: lessons learned from Mycobacterium tuberculosis.Prevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru.Insights into Pyrazinamidase and DNA Gyrase Protein Structures in Resistant and Susceptible Clinical Isolates of Mycobacterium tuberculosis.Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.

P2860

Q24800179-74C11E2A-3CB9-4041-8F1B-0F658C4341EF Q27004697-86B5271F-4090-4330-9221-72C66CFF916D Q27011264-3814BF8A-4385-4DDC-A6A7-AAB7B67DDF82 Q28485329-2B4C2CEC-16A8-4F83-94D0-03A7FFFD0AD0 Q30224832-F4A320B0-AE3E-4A4F-9DEE-A01FC1B88B87 Q30278824-263E6509-C759-4F95-B2B8-A069D6DECE1D Q30405961-A273121B-4409-4176-A68B-7CE007444FB5 Q30408918-91E8076C-6111-4925-ABE2-AF33817C7652 Q30415943-664B4D53-9E4D-4CE3-BC63-EFD58705CAE4 Q30455525-FC9716AD-D182-4390-9CE4-CB35AD4884FD Q33599760-B0D5CE66-A193-40A4-A200-7A1E016BBAAC Q33614112-555015E6-A46B-4B12-8682-EC40C195E290 Q33667486-148FD6FC-D1B5-456C-9EE9-A6ECFEFF02B1 Q33971273-BA9E9C1B-4EBB-4AC8-9E27-4A5A681B32CA Q34061907-607494B0-A807-4585-98AE-D7D4F84B33DB Q34193880-DA11FC46-42C9-48B9-B2C9-7EE877730EBE Q34230813-77D55022-17AC-4DD9-8A4C-654AB93F53C7 Q34933405-998C6E50-3BAD-44A3-B449-800AE50E88C8 Q35076847-5FB5AB2A-EAF2-4DB5-AE1A-FE3898034E92 Q35124816-8F477369-762C-4526-A5F1-C5ACA37FAD3D Q35566384-51B2E1EE-9EA9-4647-8F00-FFF6ABAFABFD Q35689060-E9A52448-636B-4ED2-93FC-ECC9F6F78F67 Q35890502-F031F96C-8A6A-4D21-8270-2D091D919BA9 Q36076037-1AFA0C26-0A1F-4816-89EF-679A91600952 Q36098662-E8BBA8D9-35E6-438D-A2B7-5BAB44EDB667 Q36297624-5D16A18D-643E-4302-8BDE-70B290D76141 Q36396241-ED6DE094-ADF8-433D-8F8C-A3E19EE4CB1F Q36597670-F3293C6B-EE60-470A-A79D-763D213927E7 Q36826734-87A61C22-9639-4899-855B-51DAC5B948C0 Q36861562-26E6B0BB-8AF2-45B2-9560-8F452553B279 Q36880482-5FA5BEE6-304E-4EDC-A61B-6D2CB433339F Q36933512-2255E4B8-4DE6-4E53-88FD-4DA8F33D4729 Q37190809-16F13CD0-4FC9-416F-BE66-A00AA49F83CB Q37358689-72884867-3B04-43A8-A126-92CDFAEFD12A Q37902409-2E30BD9B-2596-4929-97A8-2060BD4F7C6B Q38718396-E24587D1-E4BC-4C4D-85C0-D19C1AF5A2E4 Q39051351-E75B2117-AC39-4644-81ED-5E1159BECFB0 Q40091081-B4D58C02-1861-4FB5-933A-32B8C20B283A Q40328764-9FEFD509-26E2-49F8-8A4D-25D7D68BAC90 Q40734443-EBC19C13-C69A-4892-A415-B26F05E8B83A

P2860

Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.

http://www.wikidata.org/entity/Q33980394

description

2000 nî lūn-bûn

@nan

2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.

@ast

Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.

@en

type

label

Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.

@ast

Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.

@en

prefLabel

Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.

@ast

Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.

@en

P1433

Q33980394-CE2D0394-0C0D-4E4D-909E-3E89157EA6D2

P1476

Q33980394-C26FBA76-5365-4207-8F47-95251E5D5043

P2093

Q33980394-3C372369-28EC-4EC5-A7E1-D31EEFAB760F

Q33980394-539817A9-1636-4AC7-8B78-1D1C671CB4CE

Q33980394-73C14300-1B73-4191-A0F8-13FB29B11D77

Q33980394-825E155B-B0D9-47FA-92AF-8C99D1BFA93E

Q33980394-8281724C-5B61-4DD3-B7CA-43FB937E7F50

Q33980394-AAD07CCB-9820-45FF-8A43-D21F790F60A2

Q33980394-EF826F52-01B1-4E19-A3A3-6D97EDF85551

Q33980394-FB80812F-F637-4B31-8384-D3589D7EBBD1

P2860

Q33980394-078765B3-E0C9-4B94-969D-5FC6FDC715AB

Q33980394-0C5C6D67-9E9E-424F-A5BF-CEF039EB9914

Q33980394-13154D47-CC54-4172-A3FA-FB61E6406893

Q33980394-263C5D33-8E7E-4FCC-921B-BEB03BD6EFFF

Q33980394-2A10D774-CE3A-405E-84F0-B442B607F4CA

Q33980394-2CA3A856-E18B-4E52-BC60-5B63535EE07E

Q33980394-394EF3F8-81DD-4682-9AF2-BB67F85594C9

Q33980394-45550A3C-D0F2-47DA-BC7D-3866A7BE340A

Q33980394-51CB3C93-5977-4FEB-9842-F3A37E59B500

Q33980394-59F5DD99-2EE5-4C4B-95EC-A89AE7CA5F37

P304

Q33980394-A73ABE4B-F215-4FF3-A360-C426A800CA21

P31

Q33980394-864826F9-4901-436D-9A2D-82D4CAC42E10

P356

Q33980394-5D444005-48C7-44B3-BF3C-4AC6724A6941

P407

Q33980394-2D9D1FDA-C269-4C2F-8D89-C56822666CCB

P433

Q33980394-8265FB5F-4647-4180-B091-F4FF2AB5D131

P478

Q33980394-E44AAE54-D4D0-408C-8C5A-1771403A3591

P577

Q33980394-9A21E6AC-3DF7-41BB-9797-159207C8BE9A

P698

Q33980394-824FEF29-7A2A-4D4B-BE8A-BFCA784E77F1

P921

Q33980394-B93A5A0B-96DB-4682-A2D5-E8A323B28040

P932

Q33980394-718E0DFD-B948-4039-B258-D8D85265FBCA

P356

AAC.44.9.2291-2295.2000

P1433

Antimicrobial Agents and Chemotherapy

P1476

Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.

@en

P2093

Brim SE

http://www.w3.org/2001/XMLSchema#string

Butler WR

http://www.w3.org/2001/XMLSchema#string

Cooksey RC

http://www.w3.org/2001/XMLSchema#string

Crawford JT

http://www.w3.org/2001/XMLSchema#string

Mazurek GH

http://www.w3.org/2001/XMLSchema#string

Morlock GP

http://www.w3.org/2001/XMLSchema#string

Sikes D

http://www.w3.org/2001/XMLSchema#string

Woodley CL

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus

pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada

Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity

Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis

Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA

pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from northwestern Russia

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention.

Activation of pyrazinamide and nicotinamide in acidic environments in vitro.

Pyrazinamide susceptibility and amidase activity of tubercle bacilli.

Determination of drug susceptibility of mycobacteria to pyrazinamide in 7H10 agar.

P304

2291-2295

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.44.9.2291-2295.2000

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2000-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10952570

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

P932

90060

http://www.w3.org/2001/XMLSchema#string